Gynecologic Oncology (2019 IF: 4.623), an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
Gynecologic Oncology: current issue
- Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer
- High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma
- The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma
- Endometrial cancer survivors' perceptions of their cardiovascular disease risk (results from WF-1804CD AH-HA)
- Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations
- Multiplex serum immune profiling reveals circulating LAG-3 is associated with improved patient survival in high grade serous ovarian cancer
- Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis
- Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Pregnancy outcomes
- Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients
- Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study
- Understanding the spectrum of malignant bowel obstructions in gynecologic cancers and the application of the Henry score
- Safety of fertility sparing management in invasive mucinous ovarian carcinoma
- Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer
- Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma
- Laparo-endoscopic single-site versus conventional laparoscopic surgery for early-stage endometrial cancer: A randomized controlled non-inferiority trial
- The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
- Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study
- Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors
- Survival outcomes of robotic-assisted laparoscopy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis
- Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial
- Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for “low-risk” early-stage cervical cancer: A propensity-score based analysis
- Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer
- Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome
- WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study
- Identifying women 45 years and younger at elevated risk for endometrial hyperplasia or cancer
- Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study.
- Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
- Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study
- Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001)
- Guidelines for goals of care discussions in patients with gynecologic cancer